NOXA1 Antikörper (C-Term)
Kurzübersicht für NOXA1 Antikörper (C-Term) (ABIN953741)
Target
Alle NOXA1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 454-483, C-Term
-
Spezifität
- This antibody recognizes human NOXA1 at C-term.
-
Aufreinigung
- Purified through a Protein A column followed by peptide affinity purification
-
Immunogen
- Synthetic peptide - KLH conjugated - corresponding to from the C-terminal region ( between 454-483aa) of human NOXA1
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) Sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- NOXA1 (NADPH Oxidase Activator 1 (NOXA1))
-
Andere Bezeichnung
- NOXA1
-
Hintergrund
- NADPH oxidases (NOXs) catalyze the transfer of electrons from NADPH to molecular oxygen to generate reactive oxygen species (ROS). The NOX activator NOXA1 can stimulate both NOX1 and NOX2, but it appears to be more effective in activating NOX1 [Opitz et al., 2007, PubMed 17189823].Synonyms: Antigen NY-CO-31, NADPH oxidase activator, NCF2-like protein, P51NOX, P67phox-like factor, p51-nox
-
Molekulargewicht
- 50933 Da
-
Gen-ID
- 10811
-
NCBI Accession
- NP_006638
Target
-